Literature DB >> 21697021

Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice.

Tzu-Chieh Weng1, Chi-Chung Chen, Han-Siong Toh, Hung-Jen Tang.   

Abstract

BACKGROUND: Group A streptococcus (GAS) is a common cause of soft tissue infection. Nonsteroidal anti-inflammatory drugs have been reported to worsen GAS soft tissue infections.
METHODS: A mouse model of GAS soft tissue infection was developed. The extent of cutaneous lesions, tissue damage, release of inflammatory cytokines, and survival rates were compared between mice with and without ibuprofen administration after GAS soft tissue infection.
RESULTS: All twelve mice without ibuprofen administration survived for at least 10 days. In contrast, mortality rate of 14 mice with ibuprofen therapy was 72.5%. Ibuprofen-treated mice exhibited more evident macrophage infiltration and tissue damage in the GAS-infected soft tissues. In GAS-infected mice, tissue levels of interleukin 6 and tumor necrosis factor alpha were significantly higher in ibuprofen-treated mice than those in the control group.
CONCLUSIONS: The results supported the concept that ibuprofen use in GAS soft tissue infections might induce the development of severe necrotizing infections and increase mortality rate.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697021     DOI: 10.1016/j.jmii.2011.04.012

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  12 in total

1.  Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitals.

Authors:  D Lepelletier; V Pinaud; P Le Conte; C Bourigault; N Asseray; F Ballereau; J Caillon; C Ferron; C Righini; E Batard; G Potel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-04       Impact factor: 3.267

2.  Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study.

Authors:  D Lepelletier; V Pinaud; P Le Conte; C Bourigault; N Asseray; F Ballereau; J Caillon; C Ferron; C Righini; E Batard; G Potel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-07       Impact factor: 3.267

3.  Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis.

Authors:  Stephanie M Hamilton; Clifford R Bayer; Dennis L Stevens; Amy E Bryant
Journal:  J Infect Dis       Date:  2013-11-11       Impact factor: 5.226

Review 4.  The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections.

Authors:  Amy E Bryant; Clifford R Bayer; Michael J Aldape; Dennis L Stevens
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

5.  [Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

Authors:  F Speth; N Wellinghausen; J-P Haas
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

Review 6.  A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies.

Authors:  George J DeMarco; Elizabeth A Nunamaker
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

Review 7.  Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.

Authors:  Samson Sy Wong; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-07-11       Impact factor: 7.163

Review 8.  Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment.

Authors:  Danuta Wojcieszyńska; Henryk Guzik; Urszula Guzik
Journal:  Sci Total Environ       Date:  2022-04-19       Impact factor: 10.753

Review 9.  Fever: Views in Anthroposophic Medicine and Their Scientific Validity.

Authors:  David D Martin
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-24       Impact factor: 2.629

Review 10.  Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.

Authors:  Joëlle Micallef; Thomas Soeiro; Annie-Pierre Jonville-Béra
Journal:  Therapie       Date:  2020-05-07       Impact factor: 2.070

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.